Byondis is a biopharmaceutical research and development company dedicated to bringing hope to patients. With around 400 highly educated scientists and skilled technicians, our goal is to create safe and effective precision medicines that target intractable cancers and autoimmune diseases. We are committed to improving the standard of care for patients by focusing on patient-focused drug development and creating innovative therapeutic solutions for key unmet medical needs.

Our development programs center around antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs), using new biological entities to develop precision medicines. Through rigorous research and innovation, we strive to create treatments that are both safe and effective, providing tangible benefits to patients. At Byondis, we value the quality, dedication, and personality of our people, as our success and team spirit rely on them.

We are open to business and research proposals that align with our portfolio and strategy, seeking synergistic collaborations. Join us on our journey as we create precision medicines and make hope real for patients. Visit our website to learn more about our mission, team, and the work we do